Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
European Journal of Medicinal Chemistry
|
January 8, 2022
Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia
Zean Zhao, Jin Liu, Peihua Kuang, et al.
European Journal of Medicinal Chemistry
|
August 14, 2024
Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents
Zean Zhao, Xinhua Chen, Jiajun Luo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 27, 2021
Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway
Yongmei Li, Zean Zhao, Jian Luo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
October 19, 2020
Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase
Yanyu Chen, Zean Zhao, Yongmei Li, et al.
Journal of Agricultural and Food Chemistry
|
March 18, 2024
Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway
Lu Li, Kunlu Zhao, Jian Luo, et al.
Journal of Medicinal Chemistry
|
September 8, 2020
Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability
Tong Zhao, Qing Meng, Zhuosen Sun, et al.
Biochemical Pharmacology
|
August 15, 2025
5-O-Methylvisammioside, a novel inhibitor of CNT2, improves hyperuricemia by inhibiting intestinal purine nucleoside absorption with a safe profile
Suiqing Mai, Jiale Ke, Shiqin Lin, et al.
Bioorganic Chemistry
|
January 3, 2025
Discovery of cyanidin-3-O-galactoside as a novel CNT2 inhibitor for the treatment of hyperuricemia
Fengxin Zheng, Jiale Ke, Shiqin Lin, et al.
Computers in Biology and Medicine
|
February 15, 2023
Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking
Jia-Jun Luo, Xin-Hua Chen, Peng-Ying Liang, et al.
Frontiers in Pharmacology
|
February 23, 2023
L-carnitine attenuated hyperuricemia-associated left ventricular remodeling through ameliorating cardiomyocytic lipid deposition
Yang Yang, Cuiting Lin, Qiang Zheng, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
European Journal of Medicinal Chemistry
|
January 8, 2022
Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia
Zean Zhao, Jin Liu, Peihua Kuang, et al.
European Journal of Medicinal Chemistry
|
August 14, 2024
Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents
Zean Zhao, Xinhua Chen, Jiajun Luo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
May 27, 2021
Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway
Yongmei Li, Zean Zhao, Jian Luo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
October 19, 2020
Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase
Yanyu Chen, Zean Zhao, Yongmei Li, et al.
Journal of Agricultural and Food Chemistry
|
March 18, 2024
Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway
Lu Li, Kunlu Zhao, Jian Luo, et al.
Journal of Medicinal Chemistry
|
September 8, 2020
Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability
Tong Zhao, Qing Meng, Zhuosen Sun, et al.
Biochemical Pharmacology
|
August 15, 2025
5-O-Methylvisammioside, a novel inhibitor of CNT2, improves hyperuricemia by inhibiting intestinal purine nucleoside absorption with a safe profile
Suiqing Mai, Jiale Ke, Shiqin Lin, et al.
Bioorganic Chemistry
|
January 3, 2025
Discovery of cyanidin-3-O-galactoside as a novel CNT2 inhibitor for the treatment of hyperuricemia
Fengxin Zheng, Jiale Ke, Shiqin Lin, et al.
Computers in Biology and Medicine
|
February 15, 2023
Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking
Jia-Jun Luo, Xin-Hua Chen, Peng-Ying Liang, et al.
Frontiers in Pharmacology
|
February 23, 2023
L-carnitine attenuated hyperuricemia-associated left ventricular remodeling through ameliorating cardiomyocytic lipid deposition
Yang Yang, Cuiting Lin, Qiang Zheng, et al.
Page
of 3